Label: GOODSENSE EYE DROPS ADVANCED RELIEF MOISTURIZER- dextran, polyethylene glycol 400, povidone, tetrahydrozoline hcl solution

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated April 16, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active Ingredients

    Dextran 70.....0.1%

    Polyethylene glycol 400.....1%

    Povidone.....1%

    tetrahydrozoline HCl.....0.05%

  • PURPOSE

    Purposes

    Dextran 70.....Lubricant

    Polyethylene glycol 400.....Lubricant

    Povidone.....Lubricant

    Tetrahydrozoline HCl .....Redness reliever

  • INDICATIONS & USAGE

    Uses

    •
    relieves redness of the eye due to minor eye irritations
    •
    as a lubricant to prevent further irritation or to relieve dryness of the eye
  • WARNINGS

    Warnings

    For external use only

    Ask a doctor before use if you have narrow angle glaucoma

    Stop use and ask a doctor if you experience

    •
    eye pain
    •
    changes in vision
    •
    continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours

    When using this product

    •
    pupils may become enlarged temporarily
    •
    to avoid contamination, do not touch tip of container to any surface. Replace cap after using.
    •
    if solution changed color or becomes cloudy, do not use
    •
    overuse may produce increased redness of the eye
    •
    remove contact lens before using

    If pregnant or breast-feeding , ask a health professional before use.

    Keep out of reach of children. If swallowed, get medical help or contact a Poison control Center (1-800-111-1222) right away.

  • DOSAGE & ADMINISTRATION

    Directions

    Instill 1 to 2 drops in the affected eye(s) up to 4 times daily.

    Relabeled By: Preferred Pharmaceuticals Inc.

    NDC 68788-8635-1

  • INACTIVE INGREDIENT

    Inactive ingredients

    benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, and sodium chloride

  • PRINCIPAL DISPLAY PANEL

    A yellow rectangular object with black text Description automatically generated
  • INGREDIENTS AND APPEARANCE
    GOODSENSE EYE DROPS ADVANCED RELIEF MOISTURIZER 
    dextran, polyethylene glycol 400, povidone, tetrahydrozoline hcl solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-8635(NDC:50804-130)
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) (POLYETHYLENE GLYCOL 400 - UNII:B697894SGQ) POLYETHYLENE GLYCOL 4001 g  in 100 mL
    TETRAHYDROZOLINE HYDROCHLORIDE (UNII: 0YZT43HS7D) (TETRAHYDROZOLINE - UNII:S9U025Y077) TETRAHYDROZOLINE HYDROCHLORIDE0.05 g  in 100 mL
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) (POVIDONE - UNII:FZ989GH94E) POVIDONE, UNSPECIFIED1 g  in 100 mL
    DEXTRAN 70 (UNII: 7SA290YK68) (DEXTRAN 70 - UNII:7SA290YK68) DEXTRAN 700.1 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    BORIC ACID (UNII: R57ZHV85D4)  
    SODIUM BORATE (UNII: 91MBZ8H3QO)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-8635-11 in 1 CARTON04/16/2024
    115 mL in 1 CARTON; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01804/16/2024
    Labeler - Preferred PHarmaceuticals Inc. (791119022)
    Registrant - Preferred PHarmaceuticals Inc. (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred PHarmaceuticals Inc.791119022RELABEL(68788-8635)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!